A pioneering pair of cancer drugs that unleash the immune system on tumours will be paid for by the NHS in England.
A fifth of people with advanced melanoma have no sign of tumours in their body after treatment with a pair of immunotherapy drugs, a study shows.
Having more than 11 moles on one arm indicates a higher-than-average risk of skin cancer or melanoma, research suggests.
A pioneering pair of cancer drugs that unleash the immune system on tumours will be paid for by the NHS in England.
A fifth of people with advanced melanoma have no sign of tumours in their body after treatment with a pair of immunotherapy drugs, a study shows.
Having more than 11 moles on one arm indicates a higher-than-average risk of skin cancer or melanoma, research suggests.
